Yuhan teams up with Boehringer Ingelheim

Yuhan Corp. said yesterday that it has established a marketing and distribution partnership with the Germany-based pharmaceutical company Boehringer Ingelheim.

Under the deal, Dong-A will be in charge of selling Boehringer’s Trajenta (linagliptin) here starting next April, using its extensive domestic distribution network. Linagliptin will directly compete with Merck's fast-growing treatment...